43 results on '"Hernández‐Martín, A."'
Search Results
2. Cronología del diagnóstico de la neurofibromatosis tipo 1 en la infancia
- Author
-
F.J. García-Martínez and A. Hernández-Martín
- Subjects
Neurofibromatosis type 1 ,Cafe-au-lait spots ,Skin fold freckling ,Nevus anemicus ,Juvenile xanthogranuloma ,Diagnostic criteria ,Dermatology ,RL1-803 ,Internal medicine ,RC31-1245 - Abstract
Resumen: Antecedentes y objetivos: El diagnóstico de la neurofibromatosis 1 (NF1) plantea dificultades en niños sin antecedentes familiares durante la primera infancia. En este estudio pretendemos estimar la demora diagnóstica de los pacientes sin antecedentes familiares de NF1 y definir la repercusión de considerar las manchas café con leche y las efélides como un único criterio diagnóstico. Pacientes y métodos: Estudio observacional descriptivo retrospectivo en el que se revisaron los hitos diagnósticos de la NF1 en las historias clínicas de los pacientes menores de 18 años atendidos en nuestro centro. Distribuimos a los pacientes en dos grupos en función de la existencia de antecedentes de NF1 entre sus progenitores, considerando las manchas café con leche y las efélides como un único criterio y aceptando el estudio genético como criterio de confirmación en casos de elevada sospecha. Resultados: Se incluyeron en el estudio 108 menores con diagnóstico de NF1. La edad media de diagnóstico en nuestra serie fue de 3,94 años (desviación estándar: ± 3,8 años). En el grupo 1, sin antecedentes, la edad media de diagnóstico fue de 4 años y 8 meses, mientras que en el grupo 2, con antecedentes, fue de 12 meses, siendo la demora en el diagnóstico de 3 años y 8 meses entre ambos grupos. Conclusión: Las lesiones cutáneas representan, en la mayoría de los casos, las primeras manifestaciones clínicas de la enfermedad. Consideramos necesaria la actualización de los criterios diagnósticos del NIH con el fin de facilitar el diagnóstico en los primeros años de vida. Abstract: Background and objectives: The neurofibromatosis 1 (NF1) diagnosis is challenging in young children without a family history of NF1. The aims of this study were to estimate diagnostic delays in children without a family history of NF1 and to examine the effects of using café au lait macules and skin fold freckling as a single diagnostic criterion. Patients and methods: Retrospective, descriptive, observational study of all patients diagnosed with NF1 before the age of 18 years who were seen at our hospital. The medical records of those included were reviewed to identify the date on which the diagnostic criteria of NF1 were objectified. The patients were categorized into 2 groups: those with a known parental history of NF1 and those without. Café au lait macules and skin fold freckling were assessed as a single diagnostic criterion, and genetic evidence was considered to confirm highly suspicious cases. Results: We studied 108 patients younger than the age of 18 years with a diagnosis of NF1. Mean (SD) age at diagnosis was 3.94 (±3.8) years for the overall group, 1 year for patients with a parental history of NF1, and 4 years and 8 months for those without. Diagnosis was therefore delayed by 3 years and 8 months in patients without a family history. Conclusion: Skin lesions were the first clinical manifestation of NF1 in most patients. We believe that the National Institutes of Health's diagnostic criteria for NF1 should be updated to aid diagnosis in young children.
- Published
- 2023
- Full Text
- View/download PDF
3. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case–Control Study
- Author
-
F.J. García-Martínez, A. Duat-Rodríguez, E. Andrés Esteban, A. Torrelo, L. Noguera Morel, and A. Hernández-Martín
- Subjects
Neurofibromatosis tipo 1 ,Nevus anemicus ,Xantogranuloma juvenil ,fototipo ,Prurito ,Máculas café con leche ,Dermatology ,RL1-803 ,Internal medicine ,RC31-1245 - Abstract
Background: The diagnosis of Neurofibromatosis type 1 (NF1) is usually delayed in children without a family history. We aimed to define the prevalence and characteristics of prevalent skin manifestations in NF1 compared to the general population, which continue to be excluded from the diagnostic criteria for NF1. Patients and methods: Case–control study, matched by age groups, in which 108 patients with a diagnosis of NF1 and 137 healthy controls were included. Results: The prevalence of nevus anemicus (NA) (p
- Published
- 2022
- Full Text
- View/download PDF
4. Segmental infantile hemangioma: Syndromic until proven otherwise
- Author
-
Julio César Moreno-Alfonso, Sara Hernández Martín, Lidia Ayuso González, and Alberto Pérez Martínez
- Subjects
Pediatrics ,RJ1-570 - Published
- 2023
- Full Text
- View/download PDF
5. [Translated article] Neurofibromatosis Type 1: Diagnostic Timelines in Children
- Author
-
F.J. García-Martínez and A. Hernández-Martín
- Subjects
Neurofibromatosis 1 ,Manchas café con leche ,Efélides ,Nevus anémico ,Xantogranuloma juvenil ,Criterios diagnósticos ,Dermatology ,RL1-803 ,Internal medicine ,RC31-1245 - Abstract
Background and objectives: Diagnosis of neurofibromatosis 1 (NF1) diagnosis is challenging in young children without a family history of NF1. The aims of this study were to estimate diagnostic delays in children without a family history of NF1 and to examine the effects of considering café-au-lait macules and skinfold freckling as a single diagnostic criterion. Patients and methods: Retrospective, descriptive, observational study of all patients diagnosed with NF1 before the age of 18 years who were seen at our hospital. The medical records of those included were reviewed to identify the date on which the diagnostic criteria of NF1 were objectified. The patients were categorized into 2 groups: those with a known parental history of NF1 and those without. Café-au-lait macules and skinfold freckling were assessed as a single diagnostic criterion, and genetic evidence was considered to confirm highly suspicious cases. Results: We studied 108 patients younger than the age of 18 years with a diagnosis of NF1. Mean (SD) age at diagnosis was 3.94 (±3.8) years for the overall group, 1 year for patients with a parental history of NF1, and 4 years and 8 months for those without. Diagnosis was therefore delayed by 3 years and 8 months in patients without a family history. Conclusion: Skin lesions were the first clinical manifestation of NF1 in most patients. We believe that the National Institutes of Health's diagnostic criteria for NF1 should be updated to aid diagnosis in young children. Resumen: Antecedentes y objetivos: El diagnóstico de la neurofibromatosis 1 (NF1) plantea dificultades en niños sin antecedentes familiares durante la primera infancia. En este estudio pretendemos estimar la demora diagnóstica de los pacientes sin antecedentes familiares de NF1 y definir la repercusión de considerar las manchas café con leche y las efélides como un único criterio diagnóstico. Pacientes y métodos: Estudio observacional descriptivo retrospectivo en el que se revisaron los hitos diagnósticos de la NF1 en las historias clínicas de los pacientes menores de 18 años atendidos en nuestro centro. Distribuimos a los pacientes en dos grupos en función de la existencia de antecedentes de NF1 entre sus progenitores, considerando las manchas café con leche y las efélides como un único criterio y aceptando el estudio genético como criterio de confirmación en casos de elevada sospecha. Resultados: Se incluyeron en el estudio 108 menores con diagnóstico de NF1. La edad media de diagnóstico en nuestra serie fue de 3,94 años (desviación estándar: ±3,8 años). En el grupo 1, sin antecedentes, la edad media de diagnóstico fue de 4 años y 8 meses, mientras que en el grupo 2, con antecedentes, fue de 12 meses, siendo la demora en el diagnóstico de 3 años y 8 meses entre ambos grupos. Conclusión: Las lesiones cutáneas representan, en la mayoría de los casos, las primeras manifestaciones clínicas de la enfermedad. Consideramos necesaria la actualización de los criterios diagnósticos del NIH con el fin de facilitar el diagnóstico en los primeros años de vida.
- Published
- 2023
- Full Text
- View/download PDF
6. Cutaneous migrans is not only the larva
- Author
-
Julio César Moreno Alfonso, Pilar Guillén Redondo, and Sara Hernández Martín
- Subjects
Pediatrics ,RJ1-570 - Published
- 2023
- Full Text
- View/download PDF
7. Hallazgos cutáneos no considerados criterios diagnósticos de la NF1. Estudio de casos y controles
- Author
-
F.J. García-Martínez, A. Duat-Rodríguez, E. Andrés Esteban, A. Torrelo, L. Noguera Morel, and A. Hernández-Martín
- Subjects
Neurofibromatosis 1 ,Nevus anemicus ,Juvenile xanthogranuloma ,Phototype ,Pruritus ,Café-au-lait macules ,Dermatology ,RL1-803 ,Internal medicine ,RC31-1245 - Abstract
Resumen: Antecedentes: El diagnóstico de la neurofibromatosis tipo 1 (NF1) habitualmente se demora en niños sin antecedentes familiares. Nuestro objetivo fue definir la prevalencia y características de las manifestaciones cutáneas prevalentes en la NF1, en comparación con la población general, que siguen siendo excluidas de los criterios diagnósticos para NF1. Pacientes y métodos: Estudio de casos y controles, pareado por grupos de edad, en el que se incluyó a 108 pacientes diagnosticados de NF1 y 137 controles sanos. Resultados: La prevalencia de nevus anemicus (NA) (p < 0,001) y xantogranuloma juvenil (XJ) (p < 0,001) fue significativamente superior en la población afectada de NF1, en comparación con el grupo control. Se estimaron una especificidad del 99,27% (intervalo de confianza: 95,4-99,96%) y un valor predictivo positivo (VPP) del 98,80% (92,54-99,94%) para NA, y una especificidad del 99,27% (95,4-99,96%) y VPP del 92,86% (64,17-99,63%) para XJ en el diagnóstico de NF1 en niños que presentan 6 o más manchas café con leche. También se evidenciaron diferencias estadísticamente significativas en la distribución por fototipos (p = 0,025) y con el generalizado sin otra causa conocida (p
- Published
- 2022
- Full Text
- View/download PDF
8. The relationship between amplitude of low frequency fluctuations and gray matter volume of the mirror neuron system: Differences between low disability multiple sclerosis patients and healthy controls
- Author
-
Julio Plata-Bello, Yaiza Pérez-Martín, Abril Castañón-Pérez, Cristián Modroño, Estefanía Hernández-Martín, Montserrat González-Platas, Francisco Marcano, and José Luis González-Mora
- Subjects
Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
The study of the relationship between function and structure of the brain could be particularly interesting in neurodegenerative diseases like multiple sclerosis (MS).The aim of the present work is to identify differences of the amplitude of low frequency fluctuations (ALFF) in the mirror neuron system (MNS) between MS patients and healthy controls and to study the relationship between ALFF and the gray matter volume (GMV) of the regions that belong to the MNS.Relapsing-remitting MS patients with minor disability were compared to healthy controls (HC) using resting-state functional magnetic resonance imaging (fMRI), anatomic T1 weighted images and diffusion tensor imaging (DTI). Region of interest (ROI) analyses was performed in the MNS regions.A decrease of ALFF in MS patients was observed in the left inferior frontal gyrus (IFG). Furthermore, a correlation between ALFF in the IFG and the GMV of the left inferior parietal lobule (IPL) was identified. This relationship was different for MS patients than for HC, which may be associated with changes in diffusivity measures which were impaired in MS patients.MS patients with low disability may show ALFF differences in the MNS without clinical correspondence. This functional difference may be associated with cortical and subcortical changes related to the disease. Keywords: Multiple sclerosis, Mirror neuron system, Amplitude of low frequency fluctuations, Voxel based morphometry
- Published
- 2018
- Full Text
- View/download PDF
9. High resolution and fidelity 3D printing of Laponite and alginate ink hydrogels for tunable biomedical applications
- Author
-
Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, Muñoz Pérez, Elena, Pérez Valle, Arantza, Igartua Olaechea, Manuela, Santos Vizcaíno, Edorta, Hernández Martín, Rosa María, Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, Muñoz Pérez, Elena, Pérez Valle, Arantza, Igartua Olaechea, Manuela, Santos Vizcaíno, Edorta, and Hernández Martín, Rosa María
- Abstract
The formulation of hydrogels that meet the necessary flow characteristics for their extrusion-based 3D printing while providing good printability, resolution, accuracy and stability, requires long development processes. This work presents the technological development of a hydrogel-based ink of Laponite and alginate and evaluates its printing capacity. As a novelty, this article reports a standardizable protocol to quantitatively define the best printing parameters for the development of novel inks, providing new printability evaluation parameters such as the Printing Accuracy Escalation Index. As a result, this research develops a printable Laponite-Alginate hydrogel that presents printability characteristics. This ink is employed for the reproducible manufacture of 3D printed scaffolds with versatile and complex straight or curved printing patterns for a better adaptation to different final applications. Obtained constructs prove to be stable over time thanks to the optimization of a curing process. In addition, the study of the swelling and degradation behavior of the Laponite and alginate 3D printed scaffolds in different culture media allows the prediction of their behavior in future in vitro or in vivo developments. Finally, this study demonstrates the absence of cytotoxicity of the printed formulations, hence, setting the stage for their use in the field of biomedicine.
- Published
- 2023
10. Dosage of physical activity to avoid impairment of activities due to pain: analysis of population-based conditional processes
- Author
-
Universidad de Sevilla. Departamento de Enfermería, Pedro-Jiménez, Domingo de, Diego Cordero, Rocío de, Vega Escaño, Juan, Molina-Recio, Guillermo, Hernández Martín, Marta, Romero-Saldaña, Manuel, Universidad de Sevilla. Departamento de Enfermería, Pedro-Jiménez, Domingo de, Diego Cordero, Rocío de, Vega Escaño, Juan, Molina-Recio, Guillermo, Hernández Martín, Marta, and Romero-Saldaña, Manuel
- Abstract
Background: Physical activity’s established health benefits include pain control, yet there is no consensus on the required dosage according to the literature. Aim: To test the influence of exercise on perceived health in patients whose daily activities are limited due to pain. Besides, analyze the possible moderating effect of age and find a formula for exercise dosage based on the perceived level of health. Methods: Cross-sectional study based on the 2017 Spanish National Health Survey with 4,123 participants reporting activity limitations in their daily activities due to pain. The International Physical Activity Questionnaire (short version) was used to calculate energy expenditure. Data included age, sex, leisure-time physical activity, sitting time, pain-related impairments, pain medication, and perceived health. Mediation regression analysis was conducted using the SPSS PROCESS 4.0 macro. Results: Results indicate a decline in perceived health with age. The relationship between exercise (energy expenditure) and perceived health was highly significant (d=-0.224, p<0.001). Age moderated the association between pain and energy expenditure up to 75.61 years (0.1568, p=0.05) and between energy expenditure and perceived health up to 75.74 years (-0.289, p=0.05), but this effect diminished afterwards. A formula was developed to estimate energy expenditure based on the desired level of health. Conclusions: The perception of health in people who are limited in their daily activities due to pain (moderate to very much) is mediated by the amount of physical activity they perform. Besides, this perception is moderated by age, up to 76 years.
- Published
- 2023
11. Molecular Biology and Biotechnology of Horticultural Crops
- Author
-
Tafolla-Arellano, Julio César, primary, Hernández-Oñate, Miguel Ángel, additional, and Tiznado-Hernández, Martín Ernesto, additional
- Published
- 2019
- Full Text
- View/download PDF
12. Biotechnology of Horticultural Commodities
- Author
-
Ochoa-Jiménez, Verónica-Alhelí, primary, Tafolla-Arellano, Julio-César, additional, Berumen-Varela, Guillermo, additional, and Tiznado-Hernández, Martín-Ernesto, additional
- Published
- 2019
- Full Text
- View/download PDF
13. Contributors
- Author
-
Ait-Oubahou, Ahmed, primary, Ayala-Zavala, J.F., additional, Berumen-Varela, Guillermo, additional, Brecht, Jeffrey K., additional, Brecht, Patrick E., additional, Callahan, Christopher W., additional, Carrillo-López, Armando, additional, Dogan, Adem, additional, Domínguez-Avila, J. Abraham, additional, Dorta, E., additional, Elansari, Atef Mohamed, additional, Erkan, Mustafa, additional, Fadanelli, Livio, additional, Fenton, Donald L., additional, Fonseca, Jorge M., additional, Gardea-Béjar, Alfonso, additional, González-Aguilar, G.A., additional, Jamilah, B., additional, Jones, Robert W., additional, Kitinoja, Lisa, additional, Lobo, M.G., additional, López-Gámez, G.M., additional, Mattè, Pierluigi, additional, Maya-Meraz, Irma O., additional, Neven, Lisa G., additional, Nur Hanani, Z.A., additional, Ochoa-Jiménez, Verónica-Alhelí, additional, Ornelas-Paz, José de Jesús, additional, Ornelas-Paz, Juan, additional, Prakash, Anuradha, additional, Rios-Velasco, Claudio, additional, Rodríguez-Roque, Maria J., additional, Saenz, Jorge E., additional, Salas-Marina, Miguel A., additional, Sañudo, Adriana, additional, Siddiqui, Wasim, additional, Soliva-Fortuny, R., additional, Tafolla-Arellano, Julio-César, additional, Tiznado-Hernández, Martín-Ernesto, additional, Velderrain-Rodríguez, G.R., additional, and Yahia, Elhadi M., additional
- Published
- 2019
- Full Text
- View/download PDF
14. List of Contributors
- Author
-
Ali, Nusaibah Syd, primary, Alós, Enriqueta, additional, Alvarez-Parrilla, Emilio, additional, Barrera, Guadalupe Malda, additional, Bello-Perez, Luis A., additional, Bolaños, Mónica Queijeiro, additional, Botton, Alessandro, additional, Brizzolara, Stefano, additional, Cano-Lamadrid, Marina, additional, Carbonell-Barrachina, Ángel A., additional, Carrillo-López, Armando, additional, Celis, María Elena Maldonado, additional, Chen, Chunxian, additional, Chopra, Dharam Singh, additional, Cukrov, Dubravka, additional, de la Rocha, Rosabel Vélez, additional, de la Rosa, Laura A., additional, Díaz-Pérez, Juan Carlos, additional, Domínguez-Avila, J. Abraham, additional, Fotopoulos, Vasileios, additional, García-Solís, Pablo, additional, Georgiadou, Egli C., additional, González-Aguilar, Gustavo A., additional, Hernández, Francisca, additional, Hernández-Oñate, Miguel Ángel, additional, Imahori, Yoshihiro, additional, Jaafar, Ahmad Haniff, additional, Kalaitzis, Panagiotis, additional, Kaloudas, Dimitrios, additional, Kanellis, Angelos K., additional, Kumar, Ramesh, additional, Kumar, Sunil, additional, Lipan, Leontina, additional, Madani, Babak, additional, Mellidou, Ifigeneia, additional, Mirshekari, Amin, additional, Misran, Azizah, additional, Moreno-Escamilla, Jesús Omar, additional, Noguera-Artiaga, Luis, additional, Osorio, Sonia, additional, Pal, Ajay, additional, Rodrigo, Maria Jesus, additional, Rodrigo-García, Joaquín, additional, Ruperti, Benedetto, additional, Saltveit, Mikal E., additional, Sánchez-Rodríguez, Lucía, additional, Sañudo-Barajas, J. Adriana, additional, Sendra, Esther, additional, Solovchenko, Alexei, additional, Suzán-Azpiri, Humberto, additional, Tafolla-Arellano, Julio César, additional, Tiznado-Hernández, Martín Ernesto, additional, Tonutti, Pietro, additional, Vallarino, José G., additional, Yahia, Elhadi M., additional, and Zacarias, Lorenzo, additional
- Published
- 2019
- Full Text
- View/download PDF
15. No estamos solos. Motivos de consulta al gabinete médico-jurídico del sindicato médico de Murcia
- Author
-
Mariano Leal Hernández, Manuel Soto Álvarez de Sotomayor, Angel Hernández Martín, Celia Román Garcia, and Francisco Miralles Jimenez
- Subjects
Medicine (General) ,R5-920 - Published
- 2020
- Full Text
- View/download PDF
16. Ectopia renal intratorácica
- Author
-
Diego Mauricio Peñafiel-Freire, Sara Hernández-Martín, Ainhoa Iceta-Lizarraga, and Lorea Urriza-Yeregui
- Subjects
Pediatrics ,RJ1-570 - Published
- 2020
- Full Text
- View/download PDF
17. Green hemostatic sponge-like scaffold composed of soy protein and chitin for the treatment of epistaxis
- Author
-
Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, Jiménez Martín, Jon, Las Heras Zapata, Kevin, Etxabide Etxeberria, Alaitz, Uranga Gama, Jone, De la Caba Ciriza, María Coro, Guerrero Manso, Pedro Manuel, Igartua Olaechea, Manuela, Santos Vizcaíno, Edorta, Hernández Martín, Rosa María, Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, Jiménez Martín, Jon, Las Heras Zapata, Kevin, Etxabide Etxeberria, Alaitz, Uranga Gama, Jone, De la Caba Ciriza, María Coro, Guerrero Manso, Pedro Manuel, Igartua Olaechea, Manuela, Santos Vizcaíno, Edorta, and Hernández Martín, Rosa María
- Abstract
Epistaxis is one of the most common otorhinolaryngology emergencies worldwide. Although there are currently several treatments available, they present several disadvantages. This, in addition to the increasing social need of being environmentally respectful, led us to investigate whether a sponge-like scaffold (SP-CH) produced from natural by-products of the food industry - soy protein and beta-chitin - can be employed as a nasal pack for the treatment of epistaxis. To evaluate the potential of our material as a nasal pack, it was compared with two of the most commonly used nasal packs in the clinic: a basic gauze and the gold standard Merocel. Our SP-CH presented great physicochemical and mechanical properties, lost weight in aqueous medium, and could even partially degrade when incubated in blood. It was shown to be both biocompatible and hemocompatible in vitro, clearing up any doubt about its safety. It showed increased blood clotting capacity in vitro, as well as increased capacity to bind both red blood cells and platelets, compared to the standard gauze and Merocel. Finally, a rat-tail amputation model revealed that our SP-CH could even reduce bleeding time in vivo. This work, carried out from a circular economy approach, demonstrates that a green strategy can be followed to manufacture nasal packs using valorized by-products of the food industry, with equal or even better hemostatic properties than the gold standard in the clinic.
- Published
- 2022
18. Mesenchymal stromal cells encapsulated in licensing hydrogels exert delocalized systemic protection against ulcerative colitis via subcutaneous xenotransplantation
- Author
-
Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, González Pujana, Ainhoa, Beloqui García, Ana, Aguirre Anda, José Javier, Igartua Olaechea, Manuela, Santos Vizcaíno, Edorta, Hernández Martín, Rosa María, Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, González Pujana, Ainhoa, Beloqui García, Ana, Aguirre Anda, José Javier, Igartua Olaechea, Manuela, Santos Vizcaíno, Edorta, and Hernández Martín, Rosa María
- Abstract
[EN] The ability of mesenchymal stromal cells (MSCs) to release a plethora of immunomodulatory factors makes them valuable candidates to overcome inflammatory bowel diseases (IBD). However, this cell therapy approach is still limited by major issues derived from nude MSC-administration, including a rapid loss of their immunomodulatory phenotype that impairs factor secretion, low persistence and impossibility to retrieve the cells in case of adverse effects. Here, we designed a licensing hydrogel system to address these limitations and thus, obtain a continuous delivery of bioactive factors. IFN gamma-loaded heparin-coated beads were included in injectable in situ crosslinking alginate hydrogels, providing a 3D microenvironment that ensured continuous inflammatory licensing, cell persistence and implant retrievability. Licensing-hydrogel encapsulated human MSCs (hMSCs) were subcutaneously xenotransplanted in an acute mouse model of ulcerative colitis. Results showed that encapsulated hMSCs exerted a delocalized systemic protection, not presenting significant differences to healthy mice in the disease activity index, colon weight/length ratio and histological score. At day 7, cells were easily retrieved and ex vivo assays showed fully viable hMSCs that retained an immunomodulatory phenotype, as they continued secreting factors including PGE2 and Gal-9. Our data demonstrate the capacity of licensing hydrogelencapsulated hMSCs to limit the in vivo progression of IBD.
- Published
- 2022
19. Bioactive and degradable hydrogel based on human platelet-rich plasma fibrin matrix combined with oxidized alginate in a diabetic mice wound healing model
- Author
-
Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, García Orúe, Itxaso, Santos Vizcaíno, Edorta, Sánchez, Pello, Gutiérrez, Francisco Borja, Aguirre, José Javier, Hernández Martín, Rosa María, Igartua Olaechea, Manuela, Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, García Orúe, Itxaso, Santos Vizcaíno, Edorta, Sánchez, Pello, Gutiérrez, Francisco Borja, Aguirre, José Javier, Hernández Martín, Rosa María, and Igartua Olaechea, Manuela
- Abstract
[EN] In the present study we developed an injectable, bioactive and degradable hydrogel composed of alginate at 2.5% oxidation degree and calcium-activated platelet rich plasma (PRP) for wound healing applications (PRP-HG-2.5%). The alginate gives mechanical support to the hydrogel while the activated PRP provides growth factors that enhance wound healing and fibrin which creates an adequate microenvironment for cell migration and proliferation. The rheological and mechanical properties of the hydrogel were characterized. Further characterization revealed that PRPHG-2.5% showed a faster hydrolitic degradation rate than unmodified alginate and a similar platelet derived growth factor (PDGF-BB) release profile. In vitro efficacy studies, carried out in human fibroblasts and keratinocytes, showed that PRP-HG-2.5% was not cytotoxic and that it was able to promote cell adhesion and proliferation. Thereafter, in an in vivo full thickness wound healing study conducted in diabetic mice, no differences were found among PRP-HG-2.5% and its counterpart without PRP, likely due to the xenogeneic origin of the PRP. This hypothesis was validated in vitro, since a cytotoxic effect was observed after human PRP application to mouse fibroblasts. Therefore, PRP-HG-2.5% might be a promising strategy for chronic woundstreatment, although its effectiveness should be evaluated in a more reliable preclinical model.
- Published
- 2022
20. Clinical progress in MSC-based therapies for the management of severe COVID-19.
- Author
-
Farmacia y ciencias de los alimentos, Fisiología, Farmazia eta elikagaien zientziak, Fisiologia, Rosselló Gelabert, María, González Pujana, Ainhoa, Igartua Olaechea, Manuela, Santos Vizcaíno, Edorta, Hernández Martín, Rosa María, Farmacia y ciencias de los alimentos, Fisiología, Farmazia eta elikagaien zientziak, Fisiologia, Rosselló Gelabert, María, González Pujana, Ainhoa, Igartua Olaechea, Manuela, Santos Vizcaíno, Edorta, and Hernández Martín, Rosa María
- Abstract
Considering the high impact that severe Coronavirus disease 2019 (COVID-19) cases still pose on public health and their complex pharmacological management, the search for new therapeutic alternatives is essential. Mesenchymal stromal cells (MSCs) could be promising candidates as they present important immunomodulatory and anti-inflammatory properties that can combat the acute severe respiratory distress syndrome (ARDS) and the cytokine storm occurring in COVID-19, two processes that are mainly driven by an immunological misbalance. In this review, we provide a comprehensive overview of the intricate inflammatory process derived from the immune dysregulation that occurs in COVID-19, discussing the potential that the cytokines and growth factors that constitute the MSC-derived secretome present to treat the disease. Moreover, we revise the latest clinical progress made in the field, discussing the most important findings of the clinical trials conducted to date, which follow 2 different approaches: MSC-based cell therapy or the administration of the secretome by itself, as a cell-free therapy.
- Published
- 2022
21. Coste por proceso en el tratamiento quirúrgico del cáncer de piel Cost per episode of care in the surgical treatment of skin cancer
- Author
-
Ángela Hernández Martín, Antonio Núñez Reiz, Marta Sáiz Martínez, and Juan Rovirosa i Juncosa
- Subjects
Cáncer cutáneo ,Dermatología quirúrgica ,Proceso asistencial ,Coste por proceso ,Skin cancer ,Surgical dermatology ,Surgical care ,Cost per episode ,Public aspects of medicine ,RA1-1270 - Abstract
Antecedentes: El cáncer cutáneo es la neoplasia maligna más frecuente en humanos. Su tratamiento puede ser efectuado con diversas técnicas y por diferentes especialistas, y la escisión quirúrgica es el método terapéutico con menor tasa de recidivas. Objetivos: Evaluar el coste por proceso del tratamiento quirúrgico del cáncer cutáneo no melanoma (CCNM) cuando es realizado por un servicio de dermatología. Material y método: Definición del proceso asistencial como conjunto de actividades clínicas que conducen al tratamiento quirúrgico del CCNM por parte de un especialista en dermatología, y cálculo del coste por proceso empleando los datos económicos facilitados por la institución sanitaria pública en que se ha realizado el análisis. Resultados: El gasto por proceso varió entre 273,71 y 1.129,84 euros, dependiendo del procedimiento quirúrgico y de los recursos sanitarios empleados. Conclusiones: El cáncer cutáneo es una de las enfermedades dermatológicas cuyo aspecto clínico suele ser inequívoco para los dermatólogos, por lo que muchas veces ni siquiera se precisa una confirmación histológica para diagnosticarlo y decidir la pauta terapéutica correspondiente. Este hecho hace que los dermatólogos quirúrgicos sean muy eficientes, ya que el proceso se realiza con un mínimo de episodios asistencia-les y solamente en los pacientes adecuados. El coste del tratamiento varía sustancialmente en función de la complejidad de la intervención y el escenario quirúrgico donde se realiza.Background: Skin cancer is the most common form of malignancy in humans. It can be treated with various techniques and by different specialists. The procedure with the lowest failure rates is surgical excision. Objectives: To calculate the cost per episode of care in the surgical treatment of non-melanoma skin cancer (NMSC) when performed by dermatologists. Material and method: An episode of NMSC surgical care was defined as the series of healthcare services required for a dermatologist to treat skin cancer. The cost per episode was calculated using the economic data made available by the public health institution in which the analysis was performed. Results: The cost per episode of care varied between 273.71 and 1,129.84 euro, depending on the surgical procedure performed and the related health services required. Conclusions: Skin cancer is one of the cutaneous diseases with clinical manifestations that are easily recognized by dermatologists, who frequently do not even need histological confirmation to make the diagnosis and choose the therapeutic approach. Consequently, dermatological surgeons are highly efficient, since the episode of care is performed with a minimum of healthcare services and only in appropriately selected individuals. The cost of treatment varies substantially, depending on the complexity of the surgical procedures and the site where they are performed.
- Published
- 2006
22. El síndrome de burnout en funcionarios de vigilancia de un centro penitenciario
- Author
-
Lorenzo Hernández-Martín, Bernardino Fernández-Calvo, Francisco Ramos, and Israel Contador
- Subjects
Psychology ,BF1-990 - Abstract
En este trabajo ex post facto prospectivo se estudia, mediante el Maslach Burnout Inventory (MBI), el síndrome de burnout en 133 funcionarios de vigilancia de un centro penitenciario, quienes realizan una actividad laboral encaminada a garantizar la seguridad interior de la prisión. Este estudio además tiene por objeto replicar la estructura factorial del MBI y examinar la relación entre burnout y algunas variables sociodemográficas (edad, sexo, estado civil y nivel de estudios), la experiencia profesional y la categoría laboral (Vigilancia-1 y Vigilancia-2). Según los criterios de Gil- Monte y Peiró los resultados indican que el 43,60% de los sujetos padece burnout en grado alto. El análisis factorial corrobora la estructura tridimensional del MBI cansancio emocional, realización personal y despersonalización-. Los sujetos de menor edad mostraron actitudes más negativas hacia el trabajo (despersonalización) que los de mayor edad. La relación del resto de variables sociodemográficas, la experiencia profesional y categoría laboral con las tres dimensiones del burnout no resultó significativa.
- Published
- 2006
23. Cell Microencapsulation Technologies for Sustained Drug Delivery: Latest Advances in Efficacy and Biosafety
- Author
-
Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, López Méndez, Tania Belén, Santos Vizcaíno, Edorta, Pedraz Muñoz, José Luis, Orive Arroyo, Gorka, Hernández Martín, Rosa María, Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, López Méndez, Tania Belén, Santos Vizcaíno, Edorta, Pedraz Muñoz, José Luis, Orive Arroyo, Gorka, and Hernández Martín, Rosa María
- Abstract
The development of cell microencapsulation systems began several decades ago. However, today few systems have been tested in clinical trials. For this reason, in the last years, researchers have directed efforts towards trying to solve some of the key aspects that still limit efficacy and biosafety, the two major criteria that must be satisfied to reach the clinical practice. Regarding the efficacy, which is closely related to biocompatibility, substantial improvements have been made, such as the purification or chemical modification of the alginates that normally form the microspheres. Each of the components that make up the microcapsules has been carefully selected to avoid toxicities that can damage the encapsulated cells or generate an immune response leading to pericapsular fibrosis. As for the biosafety, researchers have developed biological circuits capable of actively responding to the needs of the patients to precisely and accurately release the demanded drug dose. Furthermore, the structure of the devices has been subject of study to adequately protect the encapsulated cells and prevent their spread in the body. The objective of this review is to describe the latest advances made by scientist to improve the efficacy and biosafety of cell microencapsulation systems for sustained drug delivery, also highlighting those points that still need to be optimized.
- Published
- 2021
24. Alternaria alternata (Black Rot, Black Spot)
- Author
-
Troncoso-Rojas, Rosalba, primary and Tiznado-Hernández, Martín Ernesto, additional
- Published
- 2014
- Full Text
- View/download PDF
25. List of Contributors
- Author
-
Ali, Asgar, primary, Barrera-Necha, Laura L., additional, Bautista-Baños, Silvia, additional, Bosquez-Molina, Elsa, additional, de Lapeyre de Bellaire, Luc, additional, Errampalli, Deena, additional, Feliziani, Erica, additional, Hewajulige, I.G.N., additional, Lassois, Ludivine, additional, Mari, Marta, additional, Martini, Camilla, additional, Palou, Lluís, additional, Plascencia-Jatomea, Maribel, additional, Romanazzi, Gianfranco, additional, Siddiqui, Yasmeen, additional, Tiznado-Hernández, Martín Ernesto, additional, Troncoso-Rojas, Rosalba, additional, Velez-Haro, John Martin, additional, Wijesundera, R.L.C., additional, Yépiz-Gómez, María Susana, additional, and Zhang, Jiuxu, additional
- Published
- 2014
- Full Text
- View/download PDF
26. Fruit development and ripening
- Author
-
Handa, Avtar K., primary, Tiznado-Hernández, Martín-Ernesto, additional, and Mattoo, Autar K., additional
- Published
- 2012
- Full Text
- View/download PDF
27. Contributors
- Author
-
Altman, Arie, primary, Baumann, Ute, additional, Beckles, Diane M., additional, Ben-Ari, Giora, additional, Benfey, Philip N., additional, Bischof, Sylvain, additional, Blumwald, Eduardo, additional, Hans Bohnert, J., additional, Bressan, Ray A., additional, Catalá, Rafael, additional, Cheeseman, John M., additional, Loh, Chiang Shiong, additional, Conner, Joann A., additional, Cramer, Carole, additional, Darzentas, Nikos, additional, Dassanayake, Maheshi, additional, Groote, Hugo De, additional, Dhankher, Om Parkash, additional, Díaz, Aurora, additional, Oh, Dong-Ha, additional, Doty, Sharon, additional, Engelmann, Florent, additional, Eversole, Kellye A., additional, Fleury, Delphine, additional, Gera, Abed, additional, Giritch, Anatoli, additional, Gleba, Yuri Y., additional, Gonsalves, Dennis, additional, Grant, Kannan, additional, Gressel, Jonathan, additional, Grossmann, Jonas, additional, Gruissem, Wilhelm, additional, Handa, Avtar K., additional, Hardtke, Christian S., additional, Harfouche, Antoine, additional, Hasagawa, Paul Michael, additional, Heslop-Harrison, J.S. (Pat), additional, Higgins, T.J.V., additional, Hood, Elizabeth E., additional, Huesing, Joseph E., additional, Ikeda, Takashi, additional, Xu, Jianfeng, additional, Kapazoglou, Aliki, additional, Kawaguchi, Masayo, additional, Khayat, Eli, additional, Kumar, Prakash P., additional, Langridge, Peter, additional, Lavi, Uri, additional, Lers, Amnon, additional, Loh, Chiang-Shiong, additional, Mackenzie, Sally, additional, Margam, Venu, additional, Matsui, Kenji, additional, Matsumoto, Tracie K., additional, Mattoo, Autar K., additional, Mawassi, Munir, additional, Meagher, Richard B., additional, Medrano, Giuliana, additional, Meilan, Richard, additional, Murdock, Larry L., additional, Newell-McGloughlin, Martina, additional, Nieminen, Kaisa, additional, Ozias-Akins, Peggy, additional, Peleg, Zvi, additional, Pilon-Smits, Elizabeth A.H., additional, Poirier, Yves, additional, Roessner, Ute, additional, Salinas, Julio, additional, Salomon, Dor, additional, Samach, Alon, additional, Sato, Fumihiko, additional, Schwarzacher, Trude, additional, Sessa, Guido, additional, Shiboleth, Yoel, additional, Shier, Vincent K, additional, Simmons, Blake A., additional, Taji, Acram, additional, Tapingkae, Tanya, additional, Tiznado-Hernández, Martín-Ernesto, additional, Topp, Christopher N., additional, Tsaftaris, Athanasios, additional, Tzfira, Tzvi, additional, van Beilen, Jan B., additional, Requesens, Deborah Vicuna, additional, Walia, Harkamal, additional, Watkins, Philip R., additional, Yun, Dae-Jin, additional, and Zulkarnain, Zul, additional
- Published
- 2012
- Full Text
- View/download PDF
28. Consulta de asesoramiento en vacunas: el encuentro es posible
- Author
-
María de la Parte Cancho, Iván Carabaño Aguado, Roi Piñeiro Pérez, Esther Casado Verrier, Sonsoles Galán Arévalo, Diego Hernández Martín, and Miguel Ángel Carro Rodríguez
- Subjects
03 medical and health sciences ,Vaccines ,0302 clinical medicine ,Immunisation ,030225 pediatrics ,Pediatrics, Perinatology and Child Health ,Vaccination ,030212 general & internal medicine ,Children ,Pediatrics ,RJ1-570 ,Education for health - Abstract
Resumen: Introducción: Existen recomendaciones para la toma de decisiones ante padres que no vacunan a sus hijos, pero son escasas las publicaciones que analizan este problema. En noviembre de 2014, se inaugura una consulta pionera en España, sobre asesoramiento en vacunas. El objetivo principal es dedicar tiempo y exclusividad a los padres, aplicar las recomendaciones de la AAP y la AEP, y analizar el éxito de las mismas, según el número de padres que aceptan la vacunación. Pacientes y métodos: Estudio descriptivo, transversal, prospectivo y unicéntrico llevado a cabo en el periodo del 1 de noviembre de 2014 al 1 de marzo de 2016. Se incluyen menores de 16 años no correctamente vacunados según el calendario de la comunidad autónoma donde se realiza el estudio, tras la firma del consentimiento informado. Resultados: Veinte familias acudieron a la consulta. La edad mediana de los niños fue de 2 años. El 80% no tenía ninguna vacuna administrada. El 45% de los padres mostró rechazo absoluto a la vacunación. Los principales motivos para no vacunar fueron: 100% presencia de mercurio, 90% riesgo de desarrollar autismo, 85% presencia de aluminio, 70% presencia de estabilizantes y conservantes, y 65% riesgo de desarrollar anafilaxia. Al 90% de los padres les pareció útil la consulta. Un 90% aceptaron la vacunación (45% completa). Conclusiones: El convencimiento de la filosofía antivacunas es firme y difícil de cambiar. También es complicado que los pediatras no rechacen a los padres que ponen en riesgo la vida de sus hijos. El encuentro es posible y la sociedad lo necesita. Tiempo para escuchar, empatía y trasmisión de buena información han constituido las claves de nuestros resultados. Abstract: Introduction: There are recommendations for decision-making as regards parents who do not vaccinate their children, but there are few publications analysing this problem. In November 2014, a pioneer medical clinic opened in Spain, for counselling on immunisation practices. The aim of this study is to determine the success of the recommendations of the American and Spanish Paediatrics Associations according to the number of parents who finally accept vaccination. Patients and methods: A descriptive, cross-sectional, prospective and single-centre study was conducted from November 2014 to March 2016. Children under the age of 16 not properly vaccinated, according to the immunisation schedule of the region where the study was conducted, were included after signing informed consent. Results: A total of 20 families were counselled. The median age of the children was 2 years, and 80% of them received no vaccine. Absolute non-acceptance of vaccination was practiced by 45% of parents. The main reasons for not vaccinating were: 100% thimerosal-containing, 90% risk of autism, 85% aluminium-containing, 70% presence of other stabilisers and preservatives, and 65% risk of anaphylaxis. The immunisation advice was said to be helpful by 90% of parents. Vaccination was accepted by 90% of parents (45% completely). Conclusions: Anti-vaccination ideologies are strong and hard to change. Paediatricians not denying medical care to parents who endanger the lives of their own children are also hard to find. The meeting point is possible, and society needs it. Active listening, empathy, and good quality information were the keys to our results.
- Published
- 2017
29. Type 1 Diabetes Mellitus reversal via implantation of magnetically purified microencapsulated pseudoislets
- Author
-
Farmacia y ciencias de los alimentos, Química analítica, Zoología y biología celular animal, Kimika analitikoa, Zoologia eta animalia zelulen biologia, Espona Noguera, Albert, Etxebarria Elezgarai, Jaione, Sáenz del Burgo Martínez, Laura, Cañibano Hernández, Alberto, Gurruchaga Iribar, Haritz, Blanco, Francisco Javier, Orive Arroyo, Gorka, Hernández Martín, Rosa María, Benito López, Fernando, Ciriza Astrain, Jesús, Basabe Desmonts, Lourdes, Pedraz Muñoz, José Luis, Farmacia y ciencias de los alimentos, Química analítica, Zoología y biología celular animal, Kimika analitikoa, Zoologia eta animalia zelulen biologia, Espona Noguera, Albert, Etxebarria Elezgarai, Jaione, Sáenz del Burgo Martínez, Laura, Cañibano Hernández, Alberto, Gurruchaga Iribar, Haritz, Blanco, Francisco Javier, Orive Arroyo, Gorka, Hernández Martín, Rosa María, Benito López, Fernando, Ciriza Astrain, Jesús, Basabe Desmonts, Lourdes, and Pedraz Muñoz, José Luis
- Abstract
Microencapsulation of pancreatic islets for the treatment of Type I Diabetes Mellitus (T1DM) generates a high quantity of empty microcapsules, resulting in high therapeutic graft volumes that can enhance the host’s immune response. We report a 3D printed microfluidic magnetic sorting device for microcapsules purification with the objective to reduce the number of empty microcapsules prior transplantation. In this study, INS1E pseudoislets were microencapsulated within alginate (A) and alginate-poly-L-lysine-alginate (APA) microcapsules and purified through the microfluidic device. APA microcapsules demonstrated higher mechanical integrity and stability than A microcapsules, showing better pseudoislets viability and biological function. Importantly, we obtained a reduction of the graft volume of 77.5% for A microcapsules and 78.6% for APA microcapsules. After subcutaneous implantation of induced diabetic Wistar rats with magnetically purified APA microencapsulated pseudoislets, blood glucose levels were restored into normoglycemia (< 200 mg/dL) for almost 17 weeks. In conclusion, our described microfluidic magnetic sorting device represents a great alternative approach for the graft volume reduction of microencapsulated pseudoislets and its application in T1DM disease.
- Published
- 2019
30. Características fenotípicas y genéticas en la neurofibromatosis tipo 1 en edad pediátrica
- Author
-
M.L. Ruiz-Falcó Rojas, J.M. Espejo-Saavedra Roca, G. A. Martos Moreno, Jesus Argente, A. Duat Rodríguez, Y. Martín Santo-Domingo, and A. Hernández Martín
- Subjects
NF1 gene ,Pediatrics, Perinatology and Child Health ,Optic glioma ,Ras/MAPK ,Neurofibromas ,Pediatrics ,RJ1-570 ,Neurofibromatosis type 1 - Abstract
Resumen: Introducción: La neurofibromatosis tipo 1 (NF1) es la enfermedad neurocutánea más frecuente, pero el número de trabajos en que se recogen los datos clínicos y genéticos de un número amplio de niños es escaso. Material y métodos: Se recogen los datos clínicos, epidemiológicos, radiológicos y genéticos disponibles de 239 niños con NF1, atendidos en la consulta monográfica de NF1 entre enero del 2011 y diciembre del 2013. Resultados: Doscientos treinta y nueve pacientes tenían un diagnóstico clínico y/o genético de NF1. La edad media al diagnóstico fue de 2,65 ± 2,85 años. Cumplían los siguientes criterios diagnósticos: 99,6% manchas café con leche; 93,7% efélides axilares e inguinales; 7,1% lesión ósea característica; 38,1% neurofibromas, un 23% presentaron neurofibromas plexiformes; 31,4% glioma de vía óptica; 43,1% nódulos de Lisch, y un 28% tenían un familiar de primer grado afecto de NF1. En 86 pacientes se realizó el estudio genético de NF1. Se describen las mutaciones encontradas en 72 pacientes. Además, se detallan otros datos clínicos, que, ya por su frecuencia, ya por su gravedad, han sido asociados a NF1. Conclusiones: La dificultad del diagnóstico clínico de la NF1 en edades precoces sigue siendo patente. A pesar de que se discute la necesidad o no de estudios complementarios en pacientes asintomáticos, la resonancia magnética craneal en niños con NF1 puede ser de gran ayuda en el diagnóstico clínico dada la alta incidencia del glioma de vía óptica que observamos en nuestra serie. Abstract: Introduction: Neurofibromatosis type 1 (NF1) is the most common neurocutaneous disease, nevertheless the number of publications providing clinical and genetic data from a significant number of children is limited. Material and methods: The available clinical, epidemiological, radiological and genetic data from 239 children with NF1, who attended at a specialist NF1 clinic between January 2011 and December 2013 were recorded. Results: All the 239 patients had a clinical and/or genetic diagnosis of NF1. The mean age at diagnosis was 2.65 ± 2.85 years. In our series 99.6% met the diagnostic criteria of café au lait spots, 93.7% those of axillary and inguinal freckling, 7.1% showed typical bone lesion, 38.1% neurofibromas, 23% plexiform neurofibromas, 31.4% optic pathway glioma, Lisch nodules were present in 43.1%, and 28% patients had a first degree relative affected with NF1. The NF1 genetic study was performed in 86 patients, and a description of the gene mutations found in 72 of them is presented. Furthermore, other clinical data previously associated with NF1, either because of their frequency or their severity, are detailed. Conclusions: The difficulty for clinical diagnosis of NF1 early ages is still evident. Although, the need for further studies in asymptomatic patients is discussed, cranial MRI in children with NF1 may be helpful in the clinical diagnosis, given the high frequency of optic glioma observed in this cohort.
- Published
- 2015
31. Spanish consensus on infantile haemangioma
- Author
-
Baselga Torres E, Bernabéu Wittel J, van Esso Arbolave DL, Febrer Bosch MI, Carrasco Sanz A, de Lucas Laguna R, Del Pozo Losada J, Hernández Martín Á, Jiménez Montañés L, López Gutiérrez JC, Martín-Santiago A, Redondo Bellón P, Ruíz-Canela Cáceres J, Torrelo Fernández A, Vera Casaño A, and Vicente-Villa MA
- Published
- 2016
32. Síndrome hereditario de hiperferritinemia y cataratas: mutación de novo
- Author
-
D. Hernández Martín, A. Cervera Bravo, and A. Balas Pérez
- Subjects
Genetics ,business.industry ,Pediatrics, Perinatology and Child Health ,Medicine ,business ,Pediatrics ,RJ1-570 - Published
- 2008
33. Prevalence of autosomal recessive congenital ichthyosis: A population-based study using the capture-recapture method in Spain
- Author
-
S. Ciria, Begoña Garcia-Bravo, Rogelio González-Sarmiento, Angela Hernández-Martín, Raúl de Lucas, Maria-Antonia González-Enseñat, Antonio Torrelo, Marta Feito, Ana Martín-Santiago, Laura Rodríguez-Pazos, Pablo de Unamuno, Asunción Vicente, Beatriz Aranegui, Eulalia Baselga, Manuel Ginarte, and Ignacio García-Doval
- Subjects
Adult ,Male ,Pediatrics ,medicine.medical_specialty ,Congenital ichthyosiform erythroderma ,Adolescent ,Databases, Factual ,Epidemiology ,Dermatology ,Young Adult ,Age Distribution ,Congenital ichthyosis ,medicine ,Prevalence ,Humans ,Child ,Referral and Consultation ,Aged ,Genetic testing ,Aged, 80 and over ,medicine.diagnostic_test ,business.industry ,Ichthyosis ,Health services accessibility ,Infant, Newborn ,Infant ,Ichthyosiform Erythroderma, Congenital ,Middle Aged ,Lamellar ichthyosis ,Harlequin Ichthyosis ,medicine.disease ,Confidence interval ,Spain ,Child, Preschool ,Female ,Epidemiologic Methods ,business ,Ichthyosis, Lamellar - Abstract
[Background]: Previous reports on the prevalence of autosomal recessive congenital ichthyosis (ARCI) were based on single source data, such as lists of members in a patient association. These sources are likely to be incomplete. [Objectives]: We sought to describe the prevalence of ARCI. [Methods]: We obtained data from 3 incomplete sources (dermatology departments, a genetic testing laboratory, and the Spanish ichthyosis association) and combined them using the capture-recapture method. [Results]: We identified 144 living patients with ARCI. Of these, 62.5% had classic lamellar ichthyosis and 30.6% had congenital ichthyosiform erythroderma. The age distribution included fewer elderly patients than expected. The prevalence of ARCI in patients younger than 10 years, the best estimate as less subject to bias, was 16.2 cases per million inhabitants (95% confidence interval 13.3-23.0). According to the capture-recapture model, 71% of the patients were not being followed up in reference units, 92% did not have a genetic diagnosis, and 78% were not members of the ichthyosis association. [Limitations]: The prevalence of ARCI in Spain and findings related to the Spanish health care system might not be generalizable to other countries. [Conclusions]: The prevalence of ARCI is higher than previously reported. Many patients are not being followed up in reference units, do not have a genetic diagnosis, and are not members of a patient association, indicating room for improvement in their care. Data suggesting a reduced number of older patients might imply a shorter life expectancy and this requires further study.
- Published
- 2012
34. Niño sano con síndrome de respuesta inflamatoria sistémica y shock séptico por parvovirus B19
- Author
-
A. Serrano, M.I. Iglesias-Bouzas, A. Hernández-Martín, A. García-Salido, E. Blanco-Iglesias, and Juan Casado-Flores
- Subjects
medicine.medical_specialty ,business.industry ,Shock (circulatory) ,Internal medicine ,Pediatrics, Perinatology and Child Health ,Medicine ,medicine.symptom ,business ,Gastroenterology ,Pediatrics ,RJ1-570 - Published
- 2014
35. rhegf-Loaded Plga-Alginate Microspheres Enhance The Healing Of Full-Thickness Excisional Wounds In Diabetised Wistar Rats
- Author
-
Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, Gainza Luzea, Garazi, Aguirre, José Javier, Pedraz Muñoz, José Luis, Hernández Martín, Rosa María, Igartua Olaechea, Manuela, Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, Gainza Luzea, Garazi, Aguirre, José Javier, Pedraz Muñoz, José Luis, Hernández Martín, Rosa María, and Igartua Olaechea, Manuela
- Abstract
[EN] Diabetic foot ulcers (DFUs) represent a major clinical challenge in the ageing population. To address this problem, rhEGF-loaded Poly-Lactic-co-Glycolic-Acid (PLGA)-Alginate microspheres (MS) were prepared by a modified w/o/w-doubleemulsion/ solvent evaporation method. Different formulations were evaluated with the aim of optimising MSs properties by adding NaCl to the surfactant solution and/or the solvent removal phase and adding alginate as a second polymer. The characterization of the developed MS showed that alginate incorporation increased the encapsulation efficiency (EE) and NaCl besides increasing the EE also became the particle surface smooth and regular. Once the MS were optimised, the target loading of rhEGF was increased to 1% (PLGA-Alginate MS), and particles were sterilised by gamma radiation to provide the correct dosage for in vivo studies. In vitro cell culture assays demonstrated that neither the microencapsulation nor the sterilisation process affected rhEGF bioactivity or rhEGF wound contraction. Finally, the MS were evaluated in vivo for treatment of the full-thickness wound model in diabetised Wistar rats. rhEGF MS treated animals showed a statistically significant decrease of the wound area by days 7 and 11, a complete re-epithelisation by day 11 and an earlier resolution of the inflammatory process. Overall, these findings demonstrate the promising potential of rhEGF-loaded MS (PLGA-Alginate MS) to promote faster and more effective wound healing, and suggest its possible application in DFU treatment.
- Published
- 2013
36. Prevalence of autosomal recessive congenital ichthyosis: A population-based study using the capture-recapture method in Spain
- Author
-
Hernández-Martín, Angela, Ciria, S., González-Sarmiento, Rogelio, Torrelo, Antonio, Hernández-Martín, Angela, Ciria, S., González-Sarmiento, Rogelio, and Torrelo, Antonio
- Abstract
[Background]: Previous reports on the prevalence of autosomal recessive congenital ichthyosis (ARCI) were based on single source data, such as lists of members in a patient association. These sources are likely to be incomplete. [Objectives]: We sought to describe the prevalence of ARCI. [Methods]: We obtained data from 3 incomplete sources (dermatology departments, a genetic testing laboratory, and the Spanish ichthyosis association) and combined them using the capture-recapture method. [Results]: We identified 144 living patients with ARCI. Of these, 62.5% had classic lamellar ichthyosis and 30.6% had congenital ichthyosiform erythroderma. The age distribution included fewer elderly patients than expected. The prevalence of ARCI in patients younger than 10 years, the best estimate as less subject to bias, was 16.2 cases per million inhabitants (95% confidence interval 13.3-23.0). According to the capture-recapture model, 71% of the patients were not being followed up in reference units, 92% did not have a genetic diagnosis, and 78% were not members of the ichthyosis association. [Limitations]: The prevalence of ARCI in Spain and findings related to the Spanish health care system might not be generalizable to other countries. [Conclusions]: The prevalence of ARCI is higher than previously reported. Many patients are not being followed up in reference units, do not have a genetic diagnosis, and are not members of a patient association, indicating room for improvement in their care. Data suggesting a reduced number of older patients might imply a shorter life expectancy and this requires further study.
- Published
- 2012
37. Inactivation of encapsulated cells and their therapeutic effects by means of TGL triple-fusion reporter/biosafety gene
- Author
-
Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, Santos Vizcaíno, Edorta, Larzabal, Leire, Calvo, Alfonso, Orive Arroyo, Gorka, Pedraz Muñoz, José Luis, Hernández Martín, Rosa María, Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, Santos Vizcaíno, Edorta, Larzabal, Leire, Calvo, Alfonso, Orive Arroyo, Gorka, Pedraz Muñoz, José Luis, and Hernández Martín, Rosa María
- Abstract
The immobilization of cells within alginate-poly-l-lysine-alginate (APA) microcapsules has been demonstrated to be an effective technology design for long term delivery of therapeutic products. Despite promising advances, biosafety aspects still remain to be improved. Here, we describe a complete characterization of the strategy based on TGL triple-fusion reporter gene – which codifies for Herpes Simplex virus type 1 thymidine-kinase (HSV1-TK), green fluorescent protein (GFP) and Firefly Luciferase – (SFGNESTGL) to inactivate encapsulated cells and their therapeutic effects. Myoblasts genetically engineered to secrete erythropoietin (EPO) were retroviraly transduced with the SFGNESTGL plasmid to further characterize their ganciclovir (GCV)-mediated inactivation process. GCV sensitivity of encapsulated cells was 100-fold lower when compared to cells plated onto 2D surfaces. However, the number of cells per capsule and EPO secretion decayed to less than 15% at the same time that proliferation was arrested after 14 days of GCV treatment in vitro. In vivo, ten days of GCV treatment was enough to restore the increased hematocrit levels of mice implanted with encapsulated TGL-expressing and EPO-secreting cells. Altogether, these results show that TGL triple-fusion reporter gene may be a good starting point in the search of a suitable biosafety strategy to inactivate encapsulated cells and control their therapeutic effects.
- Published
- 2012
38. Novel advances in the design of three-dimensional bio-scaffolds to control cell fate: translation from 2D to 3D
- Author
-
Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, Santos Vizcaíno, Edorta, Hernández Martín, Rosa María, Pedraz Muñoz, José Luis, Orive Arroyo, Gorka, Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, Santos Vizcaíno, Edorta, Hernández Martín, Rosa María, Pedraz Muñoz, José Luis, and Orive Arroyo, Gorka
- Abstract
Recreating the most critical aspects of the native extracellular matrix (ECM) is fundamental to understand and control the processes regulating cell fate and cell function. From the ill-defined complexity to the controlled simplicity, we discuss the different strategies that are being carried out by scientists worldwide to achieve the latest advances in the sophistication of three-dimensional (3D) scaffolds, stressing their impact on cell biology, tissue engineering and regenerative medicine. Synthetic and naturally derived polymers like polyethylene glycol, alginate, agarose, etc., together with micro- and nanofabrication techniques are allowing the creation of 3D models where biophysical and biochemical variables can be modified with high precision, orthogonality and even in real-time.
- Published
- 2012
39. Reactivity of TpMe2Ir(C2H4)(DMAD) with carboxylic acids. A DFT study on geometrical isomers and structural characterization
- Author
-
Salazar, Verónica, Sánchez-Cabrera, Gloria, Zuno-Cruz, Francisco J., Suárez-Castillo, Óscar R., Cruz, Julián, Padilla, Rosa, Hernández, Martín, Roa, Arián E., Maya, Celia, Leyva, Marco A., Rosales-Hoz, María J., Thangarasu, Pandiyan, Salazar, Verónica, Sánchez-Cabrera, Gloria, Zuno-Cruz, Francisco J., Suárez-Castillo, Óscar R., Cruz, Julián, Padilla, Rosa, Hernández, Martín, Roa, Arián E., Maya, Celia, Leyva, Marco A., Rosales-Hoz, María J., and Thangarasu, Pandiyan
- Abstract
The thermally unstable adduct TpMe2Ir(C2H4)(DMAD), which was generated “in situ” by the reaction of DMAD with TpMe2Ir(C2H4)2 (1) at low temperature, reacted with different carboxylic acids to produce the following compounds: TpMe2Ir(E-C(CO2Me)double bond; length as m-dashCH(CO2Me))(H2O)(OC(O)C6H4R), (R = H, 2a; o-OH, 2b; o-Cl, 2c; m-Cl, 2d; o-NO2, 2e; m-NO2, 2f;o-Me, 2g;p-Me, 2h) and TpMe2Ir(E-C(CO2Me)double bond; length as m-dashCH(CO2Me))(H2O)(OC(O)Me) 3. In the reaction of derivative 2a with Lewis bases, TpMe2Ir(E-C(CO2Me)double bond; length as m-dashCH(CO2Me))(L)(OC(O)C6H5), (L = Py, 4a; m-Br–Py, 4b; m-Cl–Py, 4c; NCMe, 5) were obtained, of which 4b and 4c were isolated as a mixture of two isomers in which the substituted pyridine ring was present at different rotational orientations. All new compounds prepared were characterized by 1H and 13C{1H} NMR spectroscopy, the structure of compounds 2d, 2h and 4a being determined by X-ray diffraction analysis. DFT was used to analyze the relative stability and the structural orientation of the isomers.
- Published
- 2011
40. Síndrome del cabello anágeno suelto
- Author
-
A. Torrelo Fernández, A. Hernández Martín, and N. Gallego Arbeláez
- Subjects
business.industry ,Pediatrics, Perinatology and Child Health ,Medicine ,business ,Pediatrics ,RJ1-570 - Published
- 2009
41. Improvement of the monitoring and biosafety of encapsulated cells using the SFGNESTGL triple reporter system
- Author
-
Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, Catena, Raúl, Santos Vizcaíno, Edorta, Orive Arroyo, Gorka, Hernández Martín, Rosa María, Pedraz Muñoz, José Luis, Calvo, Alfonso, Farmacia y ciencias de los alimentos, Farmazia eta elikagaien zientziak, Catena, Raúl, Santos Vizcaíno, Edorta, Orive Arroyo, Gorka, Hernández Martín, Rosa María, Pedraz Muñoz, José Luis, and Calvo, Alfonso
- Abstract
Cell microencapsulation may represent a breakthrough to overcome problems associated with cell therapy. Advances in material biocompatibility and production protocols have put this field close to its clinical application. However, issues such as the possibility of tracking cell-containing microcapsules, monitoring cell viability, and discontinuation of the therapeutic activity when necessary, still remain unsolved. We demonstrate here simultaneous monitoring and pharmacological control of myoblasts-containing alginate microcapsules, injected in immunocompetent mice after transduction with the SFGNESTGL triple reporter retroviral vector, which contains green fluorescence protein (GFP), firefly luciferase and herpes simplex virus type 1 thymidine-kinase (HSV1-TK). Naked (as controls) or microencapsulated cells were subcutaneously injected in C57BL/6J mice and followed up by luminometry. Signal for naked cells disappeared 2 weeks after cell injection, whereas signal for microencapsulated cells remained strong for 8 months, thus demonstrating the presence of living cells. Treatment of mice with the thymidine-kinase substrate ganciclovir caused death of microencapsulated myoblasts, as seen by a drastic decay in the light emission and histological analysis. Hence, we conclude that incorporation of the SFGNESTGL vector into microencapsulated cells represents an accurate tool for controlling cell location and viability in a non-invasive way. Moreover, cell death can be induced by administration of ganciclovir, in case therapy needs to be interrupted. This system may represent a step forward in the control and biosafety of cell- and gene- therapy-based microencapsulation protocols.
- Published
- 2010
42. Autoinflammatory syndromes for the dermatologist.
- Author
-
Dávila-Seijo P, Hernández-Martín A, and Torrelo A
- Subjects
- Autoimmune Diseases complications, Child, Dermatology standards, Health Status, Hereditary Autoinflammatory Diseases immunology, Humans, Immunity, Innate immunology, Inflammation immunology, Skin Diseases complications, Autoimmune Diseases diagnosis, Autoimmune Diseases immunology, Autoimmunity immunology, Hereditary Autoinflammatory Diseases diagnosis, Skin Diseases diagnosis, Skin Diseases immunology
- Abstract
While autoimmunity as cause of disease is well-established, other categories of immune-mediated diseases that are not produced by targeting of self-antigens by antibodies is in the process of being described. These so-called autoinflammatory diseases arise when an inappropriate activation of antigen-independent mechanisms occurs. Autoinflammatory diseases course with recurrent attacks of fever and multisystemic inflammation; however, the skin may also be affected by a variety of inflammatory manifestations that often alert the clinician about the presence of an autoinflammatory disease. Recognizing the cutaneous features of these syndromes will aid for prompt diagnosis and early treatment that is key for the quality of life and survival of the affected patients. In this paper, we focus on the skin manifestations of autoinflammatory diseases in children, which is the usual period of appearing of the first symptoms and signs., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
43. Horseradish peroxidase covalent grafting onto screen-printed carbon electrodes for levetiracetam chronoamperometric determination.
- Author
-
Alonso-Lomillo MA, Domínguez-Renedo O, Hernández-Martín A, and Arcos-Martínez MJ
- Subjects
- Calibration, Carbon, Diazonium Compounds, Electrochemical Techniques, Enzymes, Immobilized metabolism, Hydrogen Peroxide, Hydrogen-Ion Concentration, Indicators and Reagents, Levetiracetam, Linear Models, Piracetam analysis, Reproducibility of Results, Silver, Surface Properties, Transducers, Anticonvulsants analysis, Biosensing Techniques instrumentation, Horseradish Peroxidase metabolism, Microelectrodes, Piracetam analogs & derivatives
- Abstract
A new enzymatic electrochemical biosensor based on disposable transducers, namely screen-printed carbon electrodes, has been developed for the determination of the antiepileptic drug levetiracetam. Horseradish peroxidase was immobilized onto the carbon working electrode previously modified by an aryl diazonium salt. The formation of amide bonds between the amino and carboxylic groups of the enzyme surface, catalyzed by hydroxysuccinimide and carbodiimide, leads to the electrode functionalization. This orientated enzymatic modification results in high reproducibility, with an associated relative standard deviation of 6.21% for the slopes of several calibration curves in the calibration range from 0.10 to 0.83mM. Experimental variables that can affect levetiracetam chronoamperometric response, such as hydrogen peroxide concentration, pH, and applied potential, were optimized to perform a selective determination. An average limit of detection of 1.75x10(-5)M (alpha=beta=0.05) was obtained. The biosensors were finally applied to the determination of levetiracetam in complex matrices such as pharmaceutical drugs, yielding successful results.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.